| [1] |
SECCIA T M, RIGATO M, RAVAROTTO V, et al. ROCK (RhoA/rho kinase) in cardiovascular-renal pathophysiology: a review of new advancements[J]. J Clin Med, 2020, 9(5): 1328. DOI: 10.3390/jcm9051328.
|
| [2] |
WOJCIAK-STOTHARD B, RIDLEY A J. Rho GTPases and the regulation of endothelial permeability[J]. Vascul Pharmacol, 2002, 39(4-5): 187-199. DOI: 10.1016/s1537-1891(03)00008-9.
|
| [3] |
SO S, LEE Y, CHOI J, et al. The Rho-associated kinase inhibitor fasudil can replace Y-27632 for use in human pluripotent stem cell research[J]. PLoS One, 2020, 15(5): e0233057. DOI: 10.1371/journal.pone.0233057.
|
| [4] |
KOZUSKO S D, LIU X, RICCIO C A, et al. Selecting a free flap for soft tissue coverage in lower extremity reconstruction[J]. Injury, 2019, 50(Suppl 5): S32-S39. DOI: 10.1016/j.injury.2019. 10.045.
|
| [5] |
WANG P, GU L S, QIN Z L, et al. Efficacy and safety of topical nitroglycerin in the prevention of mastectomy flap necrosis: a systematic review and meta-analysis[J]. Sci Rep, 2020, 10(1): 6753. DOI: 10.1038/s41598-020-63721-1.
|
| [6] |
SALMAN M, SHAHZAD H, GANGARAJU R, et al. Fasudil mitigates diabetes-associated cognitive decline and enhances neuroprotection by suppressing NLRP3/Caspase-1/GSDMD signaling in a stroke mouse model[J]. Exp Neurol, 2025, 389: 115268. DOI: 10.1016/j.expneurol.2025.115268.
|
| [7] |
ZHANG W J, SHAO C Y, YU F, et al. Y-27632 promotes the repair effect of umbilical cord blood-derived endothelial progenitor cells on corneal endothelial wound healing[J]. Cornea, 2021, 40(2): 203-214. DOI: 10.1097/ICO.00000000000 02560.
|
| [8] |
PIPPARELLI A, ARSENIJEVIC Y, THURET G, et al. ROCK inhibitor enhances adhesion and wound healing of human corneal endothelial cells[J]. PLoS One, 2013, 8(4): e62095. DOI: 10.1371/journal.pone.0062095.
|
| [9] |
DING W, SU Y X, MO J S, et al. Novel artemisinin derivative P31 inhibits VEGF-induced corneal neovascularization through AKT and ERK1/2 pathways[J]. Heliyon, 2024, 10(8): e29984. DOI: 10.1016/j.heliyon.2024.e29984.
|
| [10] |
WANG H, FANG F, CHEN S F, et al. Dual efficacy of Fasudil at improvement of survival and reinnervation of flap through RhoA/ROCK/PI3K/Akt pathway[J]. Int Wound J, 2022, 19(8): 2000-2011. DOI: 10.1111/iwj.13800.
|
| [11] |
OLECK N C, GU C, PYFER B J, et al. Defining mastectomy skin flap necrosis: a systematic review of the literature and a call for standardization[J]. Plast Reconstr Surg, 2022, 149(5): 858e-866e. DOI: 10.1097/PRS.0000000000008983.
|
| [12] |
LI H L, PENG W H, JIAN W X, et al. ROCK inhibitor fasudil attenuated high glucose-induced MCP-1 and VCAM-1 expression and monocyte-endothelial cell adhesion[J]. Cardiovasc Diabetol, 2012, 11: 65. DOI: 10.1186/1475-2840-11-65.
|
| [13] |
ZHAO X Y, WANG X F, LI L, et al. Effects of high glucose on human umbilical vein endothelial cell permeability and myosin light chain phosphorylation[J]. Diabetol Metab Syndr, 2015, 7(1): 98. DOI: 10.1186/s13098-015-0098-0.
|
| [14] |
GRABOYES E M, HORNIG J D. Evolution of the anterolateral thigh free flap[J]. Curr Opin Otolaryngol Head Neck Surg, 2017, 25(5): 416-421. DOI: 10.1097/MOO.0000000000000394.
|
| [15] |
SUH J D, SERCARZ J A, ABEMAYOR E, et al. Analysis of outcome and complications in 400 cases of microvascular head and neck reconstruction[J]. Arch Otolaryngol Head Neck Surg, 2004, 130(8): 962-966. DOI: 10.1001/archotol. 130.8.962.
|
| [16] |
APTE R S, CHEN D S, FERRARA N. VEGF in signaling and disease: beyond discovery and development[J]. Cell, 2019, 176(6): 1248-1264. DOI: 10.1016/j.cell.2019.01.021.
|
| [17] |
TRIMM E, RED-HORSE K. Vascular endothelial cell development and diversity[J]. Nat Rev Cardiol, 2023, 20(3): 197-210. DOI: 10.1038/s41569-022-00770-1.
|
| [18] |
郑惠珍, 秋辉, 范爱辉. 法舒地尔促进大鼠骨髓间充质干细胞分化生成的内皮细胞迁移及血管新生[J]. 生理学报, 2009, 61(4): 339-346.
|
|
ZHENG H Z, QIU H, FAN A H. Fasudil promotes migration and vasculogenesis of endothelial cells differentiated from rat bone marrow mesenchymal stem cells in vitro[J]. Acta Physiol Sin, 2009, 61(4): 339-346.
|
| [19] |
BAO W Y, CHENG M X, CHEN X Y, et al. Effect of fasudil on clinical outcomes of pulmonary hypertension: a systematic review and meta-analysis[J]. Expert Rev Clin Pharmacol, 2024: 1-18. DOI: 10.1080/17512433.2024.2404688.
|
| [20] |
FUTTERKNECHT S, CHATZIMICHAIL E, GUGLETA K, et al. The role of rho kinase inhibitors in corneal diseases[J]. Drug Des Devel Ther, 2024, 18: 97-108. DOI: 10.2147/DDDT.S435522.
|
| [21] |
GAN L, LIAO S T, XING Y, et al. The regulatory functions of lncRNAs on angiogenesis following ischemic stroke[J]. Front Mol Neurosci, 2021, 13: 613976. DOI: 10.3389/fnmol.2020. 613976.
|
| [22] |
SPRENKELER E G G, TOOL A T J, HENRIET S S V, et al. Formation of neutrophil extracellular traps requires actin cytoskeleton rearrangements[J]. Blood, 2022, 139(21): 3166-3180. DOI: 10.1182/blood.2021013565.
|
| [23] |
YUAN Y F, KHAN S, STEWART D J, et al. Engineering blood outgrowth endothelial cells to optimize endothelial nitric oxide synthase and extracellular matrix production for coating of blood contacting surfaces[J]. Acta Biomater, 2020, 109: 109-120. DOI: 10.1016/j.actbio.2020.04.016.
|
| [24] |
TAKASE S, LIAO J Z, LIU Y, et al. Antipsychotic-like effects of fasudil, a Rho-kinase inhibitor, in a pharmacologic animal model of schizophrenia[J]. Eur J Pharmacol, 2022, 931: 175207. DOI: 10.1016/j.ejphar.2022.175207.
|
| [25] |
TSOUNAPI P, SAITO M, KITATANI K, et al. Fasudil improves the endothelial dysfunction in the aorta of spontaneously hypertensive rats[J]. Eur J Pharmacol, 2012, 691(1-3): 182-189. DOI: 10.1016/j.ejphar.2012.07.016.
|